Skip to main content
Go to homepage

Effectiveness of Ribociclib Following Radiation Therapy in Children with Newly-diagnosed Diffuse Pontine Gliomas

Effectiveness of Ribociclib Following Radiation in Children with Diffuse Pontine Gliomas

Description:

For complete information, please view the study on clinicaltrials.gov

This study is being done in collaboration with Cincinnati Children's Hospital.

Interested in participating?
We are currently recruiting
Full IRB Study Title:
CLEE011XUS17T: A Phase I/II Study of Ribociclib, a CDK4/6 Inhibitor, Following Radiation Therapy in Children with Newly-diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High-grade Gliomas (HGG)
IRB Study ID:
969528-2
Lead Investigator
Steven Kuerbitz, MD

Director, Divisional Research and Stem Cell Transplantation; Pediatric Hematologist-Oncologist
Showers Family Center for Childhood Cancer and Blood DisordersPediatric Stem Cell Transplant Program